FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Translate Bio's Free Cash Flow for the
three
months ended in Jun. 2021 was $11.2 Mil. Translate Bio's Revenue for the
three
months ended in Jun. 2021 was $72.6 Mil. Therefore, Translate Bio's FCF Margin % for the quarter that ended in Jun. 2021 was 15.38%.
The historical rank and industry rank for Translate Bio's FCF Margin % or its related term are showing as below:
TBIO'
s FCF Margin % Range Over the Past 10 Years
Min: 0 Med: 0 Max: 131.53
Current: 131.53
During the past 5 years, the highest FCF Margin % of Translate Bio was 131.53%. The lowest was 0.00%. And the median was 0.00%.
TBIO's FCF Margin % is not ranked
in the Biotechnology industry.
Industry Median: -148.935
vs TBIO: 131.53
Translate Bio FCF Margin % Historical Data
The historical data trend for Translate Bio's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Translate Bio's FCF Margin %
For the Biotechnology subindustry, Translate Bio's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Translate Bio's FCF Margin % Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Translate Bio's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Translate Bio's FCF Margin % falls into.
Translate Bio FCF Margin % Calculation
FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.
Translate Bio's FCF Margin for the fiscal year that ended in Dec. 2020 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Translate Bio FCF Margin % Related Terms
Thank you for viewing the detailed overview of Translate Bio's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.
Translate Bio (Translate Bio) Business Description
Translate Bio Inc is a clinical-stage mRNA therapeutics company developing a new class of potentially transformative medicines to treat diseases caused by protein or gene dysfunction. The company is developing MRT5005, for the treatment of cystic fibrosis (CF) and MRT5201, for the treatment of ornithine transcarbamylase (OTC) deficiency.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
TBIO has been successfully added to your 